9.49
Conexeu Sciences Inc (CNXU) 最新ニュース
Conex Completes 12-Month P.R.O.O.F Preclinical Study, Targets Q1 2027 510(k) for Wound Care - TradingView
[8-K] Conexeu Sciences Inc. Reports Material Event - Stock Titan
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It - PR Newswire
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat
Conexeu Sciences (CNXU) Insider Trading Activity 2026 - MarketBeat
Enterprise value to EBITDA forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Conexeu Sciences (CNXU) Earnings Date and Reports 2026 - MarketBeat
Conexeu Sciences Inc. Common Stock (NASDAQ: CNXU) Stock Price, News & Analysis - Kalkine
Price to book forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Enterprise value to revenue forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Price to sales forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity - Investing News Network
CNXU News Today | Why did Conexeu Sciences stock go up today? - MarketBeat
Conexeu Sciences (CNXU) Stock Forecast and Price Target 2026 - MarketBeat
Conexeu Sciences : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
50,000 options reported by Conexeu Sciences (CNXU) director - Stock Titan
Conexeu Sciences (CNXU) 10K Form and Latest SEC Filings 2026 - MarketBeat
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CNXU Forecast — Price Target — Prediction for 2027 - TradingView
Conexeu Sciences, Inc. Actuals & Estimates (NASDAQ:CNXU) - TradingView
Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - MarketBeat
Conexeu Sciences opens R&D facility in Vancouver - Investing.com
The Aesthetics Giants Just Confirmed "Ozempic Face" Is Realand a Newly Public Regenerative Player Wants to Compete for It - Investing News Network
Conexeu Sciences opens R&D facility in Vancouver By Investing.com - Investing.com Australia
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform - The Manila Times
Conexeu Launches R&D Facility at M4 to Innovate Wound Healing Tech - techcouver.com
Conexeu Sciences Inc.: Target Price Consensus and Analysts Recommendations | CNXU | US20715F1003 - marketscreener.com
Conexeu Sciences (CNXU) director holds 50K options at $2.30, 2031 expiry - Stock Titan
Conexeu Sciences aims for FDA clearance by 2027 with a promising regenerative medicine product. - Pluang
Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission - Seeking Alpha
Insider Stock Purchases: June 24, 2026 - Moomoo
TradingKey - TradingKey
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Conexeu Sciences Ord Shs (CNXU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Conexeu Sciences Ord Shs (CNXU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Conexeu Sciences Ord Shs (CNXU) Valuation: PE, PB & Fair Value Analysis - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.860|Chg%:0.60 - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.360|Chg%:-0.33 - TradingKey
Conexeu Sciences Ord Shs (CNXU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Conexeu Sciences Ord Shs (CNXU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Conexeu Sciences Ord Shs (CNXU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.820|Chg%:0.27 - TradingKey
[Form 3] Conexeu Sciences Inc. Initial Statement of Beneficial Ownership - Stock Titan
Insider at Conexeu Sciences (CNXU) adds common stock and warrants - Stock Titan
Homegrown biotech firm launches new R&D lab space in Vancouver - Business in Vancouver
This Credo Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
H.C. Wainwright Initiates Conexeu Sciences(CNXU.US) With Buy Rating, Announces Target Price $20 - Moomoo
Conexeu Sciences (CNXU) 10% owner exercises 250K warrants via N3GU - Stock Titan
Conexeu Sciences initiated with a Buy at H.C. Wainwright - TipRanks
CNXU Initiates Coverage by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
Conexeu Sciences stock initiated at buy by H.C. Wainwright, $20 target - Investing.com South Africa
大文字化:
|
ボリューム (24 時間):